Actiza Pharmaceutical Private Limited

3β,5-Dihydroxy-6β,7β:15β,16β-dimethylene-5β-androstan-17-one is a synthetic steroid derivative that serves as an important intermediate in pharmaceutical research and drug development. This compound is primarily used in the preparation of various androgenic and anabolic agents due to its unique structural features, including multiple hydroxyl groups and methylene bridges. Its steroidal backbone and modifications make it valuable in the synthesis of hormone-related drugs, especially those targeting androgen receptors or used in hormonal therapies.